Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.

[1]  J. Jonas.  VERTEPORFIN THERAPY OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION: Meta-Analysis of 2-Year Safety Results in Three Randomized Clinical Trials: Treatment of Age-Related Macular Degeneration with Photodynamic Therapy and Verteporfin in Photodynamic Therapy Study Report , 2002, American journal of ophthalmology.

[2]  Simon P. Harding,et al.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2. , 2001, American journal of ophthalmology.

[3]  N. Bressler,et al.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.

[4]  N. Bressler,et al.  A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. , 2000, Archives of ophthalmology.

[5]  R. Danis,et al.  Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization. , 1999, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[6]  R Birngruber,et al.  Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. , 1999, Archives of ophthalmology.

[7]  R Birngruber,et al.  Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. , 1999, Archives of ophthalmology.

[8]  Liem Se,et al.  Proton-beam irradiation of subfoveal choroidal neovascular membranes in presumed ocular histoplasmosis syndrome : a case report , 1998 .

[9]  H. Kaplan,et al.  Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis. , 1997, Archives of ophthalmology.

[10]  N. Holekamp,et al.  Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis: stability of early visual results. , 1997, Ophthalmology.

[11]  S. Valluri,et al.  Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome. , 1996, Ophthalmology.

[12]  Joan W. Miller,et al.  Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. , 1996, Ophthalmology.

[13]  N. Bressler,et al.  Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: results of a pilot randomized clinical trial. , 1993, Archives of ophthalmology.

[14]  S. Fine,et al.  Subfoveal neovascularization in the ocular histoplasmosis syndrome. A natural history study. , 1988, Retina.

[15]  G. Fish,et al.  Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group. , 1987, Archives of ophthalmology.

[16]  D. Burgess,et al.  Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis. , 1984, Ophthalmology.

[17]  Schlaegel Tf.  Corticosteroids in the treatment of ocular histoplasmosis. , 1983 .

[18]  J. Gass,et al.  Follow-up study of presumed ocular histoplasmosis syndrome. , 1980, Ophthalmology.

[19]  C. Palmer,et al.  An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. , 1969, The American review of respiratory disease.